Lactoferrin was ranked as medium potential (Fig. 3c), and there is evidence from a small trial of 125 pregnant women with bacterial vaginosis that vaginal lactoferrin significantly reduced the rate of preterm birth (25.0% vs 44.6%, p = 0.02) [40]. The gene discussed is LTF; the disease is bacterial vaginosis.